Adam Greenbaum on Muck Rack

Adam Greenbaum

Newport Beach
As seen in: WhiskerTalks: A Veterinary Podcast, Medium, HuffPost, Voice of America (VOA), The Stranger, AHA/ASA Journals, EIN News, Tech.co, EIN Presswire, Journal of Invasive Cardiology, JACC (Journal of the American College of Cardiology) and
@lizzzlybear’s husband. Dog + cat dad. 🚀 2x Founder with one life-changing exit, 1x Global CMO ⭐️ Investor, Mentor, Builder in the Pet Industry

Get in touch with Adam

Contact Adam, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Adam Greenbaum’s Biography

Read Full Bio →

Adam Greenbaum is an award-winning digital marketer with experience ranging from a boutique advertising agency to a national travel agency, and everything in between. Most digital marketers pride themselves on specializing in one particular aspect of marketing – social media, web design, analytics, email marketing, search engine marketing – Adam specializes in all of it. Most startups and small businesses don’t have the bandwidth or budget to hire an entire marketing department, Greenbaum Digit…

Articles

Protect the H2H Trial: Randomized Comparison of Emboliner Embolic Protection Catheter vs Sentinel Cerebral Protection System During Transcatheter Aortic Valve Replacement

|
By Adam Greenbaum
| Journal of Invasive Cardiology
Transcript: Hi, my name is Adam Greenbaum. I’m one of the co-directors of the Structural Heart and Valve Center at Emory University in Atlanta, Georgia, and I’m here to discuss the Protect the Head-to-Head (H2H) study, recently released at the American College of Cardiology (ACC) Conference in New Orleans. Results showed similar 30-day outcomes for Emboliner and Sentinel, higher technical success for Emboliner, but also longer procedure times for Emboliner.
Open in Who Shared Issue with article?

Protect the head to head trial: Randomized comparison of emboliner embolic protection catheter vs. sentinel cerebral protection system during transcatheter aortic valve replacement

|
By Alessandro Sticchi, Adam Greenbaum
| PCR Online
Reported from ACC.26 Alex Sticchi interviews Adam B. Greenbaum on the PROTECT head-to-head trial, comparing the new full-body Emboliner device with the first-generation Sentinel during TAVR, as presented at ACC.26 in New Orleans. In ~250 patients per group, Emboliner captured about three times more debris and had higher technical success, while both devices showed similar 30-day outcomes for death, stroke, or vascular complications and stroke rates.
Open in Who Shared Issue with article?

Love, Baxter and Zoundz Partner to Support Chronically Ill and Senior Pets

|
By Adam Greenbaum
| EIN Presswire
Special playlists for senior and sick pets. New collaboration helps pet parents support their pet’s emotional well-being through science-backed sound therapy during life’s most challenging stages.
Open in Who Shared View Duplicates (42) Issue with article?
See all 31 licensed articles (36 Total)

Interview

Have you ever used a typewriter?

Yes, my grammar was never better our of fear of mistakes.

What advice can you offer to aspiring journalists?

Hustle hard and don't take no for an answer.

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Get in touch with Adam

Contact Adam, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified